BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1312162)

  • 1. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.
    Griffiths RR; Sannerud CA; Ator NA; Brady JV
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1199-208. PubMed ID: 1312162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
    Weerts EM; Griffiths RR
    Behav Pharmacol; 1998 May; 9(3):285-97. PubMed ID: 9832941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
    Rowlett JK; Woolverton WL
    J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between discriminative and reinforcing effects of midazolam, pentobarbital, chlordiazepoxide, zolpidem, and imidazenil in baboons.
    Ator NA
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):477-87. PubMed ID: 12373448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
    Rowlett JK; Spealman RD; Lelas S
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
    Weerts EM; Ator NA; Grech DM; Griffiths RR
    J Pharmacol Exp Ther; 1998 Apr; 285(1):41-53. PubMed ID: 9535993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral pharmacology of abecarnil in baboons: self-injection, drug discrimination and physical dependence.
    Sannerud CA; Ator NA; Griffiths RR
    Behav Pharmacol; 1992 Oct; 3(5):507-516. PubMed ID: 11224153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity in the generalization profile in baboons trained to discriminate lorazepam: benzodiazepines, barbiturates and other sedative/anxiolytics.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1442-57. PubMed ID: 9316858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methocarbamol: evaluation of reinforcing and discriminative stimulus effects.
    Sannerud CA; Ator NA; Griffiths RR
    Behav Pharmacol; 1991 Apr; 2(2):143-150. PubMed ID: 11224058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
    Sannerud CA; Ator NA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):183-93. PubMed ID: 7562548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of atypical anxiolytics in baboons and rats.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1986 May; 237(2):393-403. PubMed ID: 2871171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788.
    Ator NA; Griffiths RR
    J Pharmacol Exp Ther; 1983 Sep; 226(3):776-82. PubMed ID: 6136600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
    Ator NA
    Drug Alcohol Depend; 2000 Dec; 61(1):55-68. PubMed ID: 11064184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
    Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
    Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral pharmacology of tandospirone in baboons: chronic administration and withdrawal, self-injection and drug discrimination.
    Sannerud CA; Ator NA; Griffiths RR
    Drug Alcohol Depend; 1993 May; 32(3):195-208. PubMed ID: 8102330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of benzodiazepine agonists and partial agonists in pentobarbital-trained rhesus monkeys.
    Rowlett JK; Woolverton WL
    Behav Pharmacol; 1998 Mar; 9(2):81-92. PubMed ID: 10065928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses.
    Rowlett JK; Lelas S
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):328-37. PubMed ID: 17696679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.